deamino-arginine-vasopressin and Pulmonary-Fibrosis

deamino-arginine-vasopressin has been researched along with Pulmonary-Fibrosis* in 2 studies

Other Studies

2 other study(ies) available for deamino-arginine-vasopressin and Pulmonary-Fibrosis

ArticleYear
Successful bilateral lung transplantation for pulmonary fibrosis associated with the Hermansky-Pudlak syndrome.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2005, Volume: 24, Issue:10

    Hermansky-Pudlak syndrome (HPS) is a genetic disorder characterized by oculocutaneous albinism, a bleeding diathesis, and in a subset of patients, pulmonary fibrosis. Lung transplantation, the only curative therapy for pulmonary fibrosis, has not been previously reported as a successful treatment strategy for patients with HPS because the bleeding diathesis was thought to contraindicate major thoracic surgery. We successfully performed bilateral sequential lung transplantation in a patient with pulmonary fibrosis and HPS after transfusion of 6 units of platelets. Lung transplantation is a viable therapeutic option in patients with pulmonary fibrosis and only a mild bleeding diathesis associated with HPS.

    Topics: Adult; Blood Platelet Disorders; Deamino Arginine Vasopressin; Hemorrhagic Disorders; Hemostatics; Hermanski-Pudlak Syndrome; Humans; Lung Transplantation; Male; Membrane Proteins; Platelet Transfusion; Pulmonary Fibrosis; Treatment Outcome

2005
[Hypersensitivity against vasopressin and the synthetic vasopressin-analog DDAVP].
    MMW, Munchener medizinische Wochenschrift, 1982, May-14, Volume: 124, Issue:19

    Topics: Administration, Intranasal; Adult; Arginine Vasopressin; Asthma; Deamino Arginine Vasopressin; Diabetes Insipidus; Drug Hypersensitivity; Humans; Male; Pulmonary Fibrosis; Vasopressins

1982